Customers to Benefit from an Open Business Model

Cegedim Dendrite today announced the expansion of its Alliance Program at the eyeforpharma Sales Force Effectiveness (SFE) Europe 2009 Conference. Embracing an Open Business Model, Cegedim Dendrite is expanding formal partnerships with selected technology, software and consulting companies in order to provide additional capabilities and services to customers. Cegedim Dendrite is the leading provider of Customer Relationship Management (CRM) solutions to the pharmaceutical industry.

Pharmaceutical and life science companies are looking for solutions that will facilitate incremental growth, increased productivity and effectiveness. Cegedim Dendrite meets this need by providing tools that are optimally adapted to address the complex problems of the medical information business. With the Open Model, industry leading solutions are now enhanced by strategic alliances which will ensure the availability of complementary products and services aimed at delivering total customer satisfaction.

“An Open Business Model – particularly partnerships with other industry leaders – fosters innovation and improved customer satisfaction,” stated Laurent Labrune, Chief Executive Officer at Cegedim Dendrite. “We will be building strong partnerships with other best-of-breed companies that have offerings that complement our products and services, in order to give our customers a technological edge in a very competitive market.”

The Alliance Program will accommodate three different types of businesses. Technology Partners are companies that offer technology and platform solutions that support and enhance the performance of Cegedim Dendrite business applications. Software Partners are companies with software products that complement Cegedim Dendrite’s applications. Consulting Partners provide a range of services associated with the optimal use of Cegedim Dendrite products and services.

“We are very excited about partnering with Cegedim Dendrite due to their leadership and innovation as a partner to the pharmaceutical and life science industry,” said Pierre Germain, Associate Director, Life Sciences for Capgemini. “We are confident that break-through solutions will be delivered to the market through the collaboration of the two companies.